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Abstract
Introduction: Treatment of coronary artery involvement in Takayasu’s arteritis is challenging. Coronary artery bypass
grafting may be required. The use of saphenous vein grafts is recommended because of possible inflammatory
involvement of the internal thoracic arteries. However, inserting the proximal anastomosis on inflamed aortic tissue
may give rise to stenosis. Only a few cases of inserting a proximal anastomosis in patients with Takayasu’s arteritis
have been reported in the literature. To date, no consensus has been reached on the best way to perform this
procedure in patients with Takayasu’s arteritis.
Case presentation: We report a case of a 25-year-old white woman with Takayasu’s arteritis who had recurrent
angina after two previous treatments had failed, due to left main stem stenosis. She was successfully treated by
coronary artery bypass grafting using a Dacron patch to insert the proximal anastomosis.
Conclusions: We are the first to report an uncomplicated case in which a Dacron (Vascutek®, Renfrewshire)
prosthetic patch was used to insert the proximal anastomosis on an inflamed aorta in a patient with Takayasu’s
arteritis. The patch prevents contact between inflamed tissue and the graft, which we believe reduces the risk of
graft failure. This case might inspire other thoracic surgeons in the challenging task of performing
revascularization techniques in patients with an inflamed and fragile aorta.
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Introduction
Takayasu’s arteritis (TA) is an idiopathic vasculitis
which mainly affects the aorta and proximal parts of
its major branches. TA mostly occurs in women in
their second or third decade and has a worldwide
distribution, although the disease seems to have a
higher incidence in Southeast Asia, South Africa and
Latin America [1]. In 10 to 30 % of cases of TA there
is coronary involvement, with the left coronary ostia
most frequently affected, sometimes requiring coronary
artery bypass grafting (CABG) [2, 3]. Surgical treatment of
coronary involvement in TA is challenging due to the ne-
cessity to manipulate fragile and inflamed aortic tissue [4].
The internal mammary arteries are often affected by
the disease, which may render their use unsuitable
in CABG. Therefore saphenous venous grafts (SVGs)
are mostly used in CABG in patients with TA [2, 3].
Severely inflamed and calcified lesions of the ascend-
ing aorta, however, make the SVG anastomosis to
the aorta rather precarious. This fragile proximal
anastomosis leads to increased postoperative compli-
cations such as hemorrhage and high rates of early
graft failure [2, 5].
We report the case of a patient with a documented
history of TA resulting in occlusion of her left main
coronary artery who received a CABG in 2004: left in-
ternal thoracic artery (LITA)-left ascending artery
(LAD). In 2012 she repeatedly had severe angina due to
graft failure and was successfully treated by re-CABG
using a Dacron (Vascutek®, Renfrewshire) patch on her
aorta for the proximal anastomosis.
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Case presentation
A 25-year-old white woman with a documented history
of TA and total occlusion of her left main coronary
artery received a CABG (LITA-LAD) in 2004. In 2012,
two episodes of angina, due to graft failure, were treated
by percutaneous coronary interventions using a Xience
Prime drug-eluting stent. Unfortunately she was referred
back to our hospital with signs of unstable angina after
an initial symptom-free period of 4 months. During this
period she received two platelet inhibitors (ticagrelor 90
mg, orally twice a day and Ascal (carbasalate calcium)
80 mg once a day), metoprolol 150 mg, ramipril 2.5 mg,
simvastatin 40 mg, isosorbide mononitrate 60 mg twice
a day and one dose of methotrexate (2 mg) every week
in combination with folic acid. A clinical examination
showed no abnormalities, besides a significant differ-
ence in blood pressure to the prejudice of the left
side with absent radial pulsations. Her chest X-ray
showed a normal heart size. A 12-lead electrocardiogram
showed T-wave depression in the precordial and lateral
leads. Blood biochemical and hematological parameters,
including cardiac enzymes, were within normal range. A
computed tomography angiogram was performed reveal-
ing a thickened aortic wall at the level of the aortic arch
with a normal diameter and occlusion of her left sub-
clavian and left pulmonary artery. The coronary angio-
gram revealed a total occlusion of her left main coronary
artery and recurrent graft failure, with significant double
in-stent restenosis of 99 % in the LITA-LAD. Her left
coronary system was filled by collaterals from the right,
dominant, system (Fig. 1).
In consultation with the patient we decided on a re-
CABG using a Dacron (Vascutek®, Renfrewshire) patch
on her aorta for the proximal anastomosis which was
performed on 6 September 2012. Intraoperatively we en-
countered a thickened and inflamed aortic wall, in which
the left lateral side was severely affected. We performed
redo CABG using a SVG to the anterolateral, first diag-
onal and LAD. For the proximal anastomosis an oval
Dacron (Vascutek®, Renfrewshire) patch was tailor-made
by the surgeon and attached to her side-clamped aorta.
Subsequently, the venous graft was sutured into the
patch using prolene. Biopsies from the ascending aortic
wall and the LITA proximal to the stent were taken.
Histological examination of the aortic wall specimen
demonstrated extensive changes including significant in-
tima proliferation without calcification and a nonspecific
chronic inflammatory response with widespread fibrosis
(Fig. 2). The LITA specimen showed some reactive
changes but no specific inflammatory characteristics.
Both the intraoperative and postoperative courses were
uneventful and the patient was discharged 5 days after
surgery. Fraxiparine (nadroparin) injections (0.3 ml)
were added to the medical regimen and Ascal (carbasa-
late calcium) dosage was increased to a 100 mg once a
day.
Since then, the patient routinely visits the cardiology
out-patient clinic. Her last examination (October 2015)
revealed no signs of recurrent coronary perfusion prob-
lems: she reported no angina complaints during exer-
cise, an electrocardiogram revealed no abnormalities
and echocardiography showed no signs of left ventricu-
lar dysfunction or wall-motion abnormalities. Since
December 2014 she stopped taking methotrexate
because of an active pregnancy wish. Despite the
withdrawal of immunosuppressive medication her TA
is still in remission to date.
Discussion
Coronary involvement in patients with TA is frequently
seen. There are many revascularization methods such as
endarterectomy, percutaneous transluminal angioplasty
(PTA), drug-eluting stents, ostioplasty and CABG, of
which the optimal method is yet to be determined. Since
patch angioplasty and endarterectomy are associated with
higher long-term restenosis rates, surgical procedures with
bypass grafts seem preferable [6–8]. Coronary lesions in
patients with TA are mostly located at the ostia or the
proximal coronary segment of the left main coronary
artery and these locations are deemed unsuitable for
percutaneous techniques [9]. Unfortunately, CABG in
patients with TA brings many difficulties. Due to possible
Fig. 1 Coronary angiogram showing a total occlusion of the left system (left) with collateral filling from the right, dominant system (middle).
Operation technique: a venous graft sutured into a tailor-made Dacron patch on the ascending aorta (right)
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involvement of the internal mammary arteries in TA,
SVGs are mostly used as graft material [2, 3]. Using SVGs,
restenosis rates up to 50 % have been reported, which are
significantly higher compared to rates of patients with
coronary disease due to atherosclerosis [10]. Occlusion of
the proximal ostium of the anastomosed site, resulting
from intimal hypertrophy, is the most reported late
complication in patients with TA undergoing CABG [11].
To avoid graft failure and complications caused by
manipulating an inflamed aorta, different techniques have
been described to attach the SVG to the aorta. If possible,
the proximal anastomosis should be sutured on a healthy
region of the ascending aorta and the operation should
preferably be performed in a non-active stage of the
disease. In addition, postoperative use of steroids is
recommended in patients with clinical and serological
signs of active disease.
Only few cases of inserting a proximal anastomosis in
patients with TA have been reported in the literature.
For example Yamaguchi et al. reported a case were
aortic connectors were employed for the proximal
anastomosis in an off-pump CABG [12]. Using the
connectors, the proximal anastomosis can be made
faster and without clamping the ascending aorta. The
procedure is impossible if there is no suitable place for
the connector on a severely inflamed aorta [12]. Another
way to prevent SVG occlusion caused by inflamed aortic
tissue is to insert the proximal anastomosis on an
autogenous pericardial patch or on a prosthetic patch
[13]. Others described the use of a pericardial patch to
combine coronary ostioplasty with insertion of the
proximal anastomoses [14]. Despite the abovementioned
techniques complication rates remain high, and there is
a need for improvement. In particular, literature reports
are inconclusive about the best way to insert the
proximal anastomosis in CABG.
Conclusions
No consensus has been reached on the best way to
insert a proximal anastomosis on inflamed aortic tissue.
We are the first to report an uncomplicated case in
which a Dacron (Vascutek®, Renfrewshire) prosthetic
patch was used to insert the proximal anastomosis on an
inflamed aorta. The patch prevents contact between
inflamed tissue and the graft, which we believe reduces
the risk of graft failure.
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